<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Secbutonitazene</id>
	<title>Secbutonitazene - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Secbutonitazene"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Secbutonitazene&amp;action=history"/>
	<updated>2026-04-25T11:16:24Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Secbutonitazene&amp;diff=6428623&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Secbutonitazene&amp;diff=6428623&amp;oldid=prev"/>
		<updated>2025-03-05T06:39:10Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Secbutonitazene ==&lt;br /&gt;
&lt;br /&gt;
[[File:Secbutylnitazene_structure.png|Structure of Secbutonitazene|thumb|right]]&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Secbutonitazene&amp;#039;&amp;#039;&amp;#039; is a synthetic opioid analgesic that belongs to the benzimidazole class of compounds. It is structurally related to other nitazene derivatives, which are known for their potent opioid effects. Secbutonitazene has gained attention due to its high potency and potential for abuse, similar to other synthetic opioids.&lt;br /&gt;
&lt;br /&gt;
== Chemical Structure and Properties ==&lt;br /&gt;
&lt;br /&gt;
Secbutonitazene is characterized by its benzimidazole core structure, which is a common feature among nitazene derivatives. The chemical structure of Secbutonitazene includes a sec-butyl group, which differentiates it from other related compounds. This structural modification contributes to its unique pharmacological profile.&lt;br /&gt;
&lt;br /&gt;
The molecular formula of Secbutonitazene is C&amp;lt;sub&amp;gt;23&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;30&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;, and it has a molecular weight of approximately 394.52 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
Secbutonitazene acts as a potent agonist at the [[mu-opioid receptor]], which is the primary target for opioid analgesics. Activation of these receptors results in analgesic effects, as well as the potential for euphoria, respiratory depression, and physical dependence. The potency of Secbutonitazene is reported to be significantly higher than that of morphine, making it a substance of concern in terms of overdose risk.&lt;br /&gt;
&lt;br /&gt;
== Medical Use and Regulation ==&lt;br /&gt;
&lt;br /&gt;
Currently, Secbutonitazene does not have any approved medical uses. It is primarily encountered in the context of illicit drug use. Due to its high potency and potential for abuse, Secbutonitazene is subject to regulatory control in many jurisdictions. It is often classified as a controlled substance, and its distribution and use are heavily restricted.&lt;br /&gt;
&lt;br /&gt;
== Risks and Concerns ==&lt;br /&gt;
&lt;br /&gt;
The primary risks associated with Secbutonitazene are related to its high potency and the potential for overdose. Like other potent opioids, it can cause severe respiratory depression, which can be fatal if not promptly treated. The risk of overdose is particularly high when Secbutonitazene is used in combination with other central nervous system depressants, such as alcohol or benzodiazepines.&lt;br /&gt;
&lt;br /&gt;
== Related Pages ==&lt;br /&gt;
&lt;br /&gt;
* [[Opioid]]&lt;br /&gt;
* [[Benzimidazole]]&lt;br /&gt;
* [[Mu-opioid receptor]]&lt;br /&gt;
* [[Synthetic opioid]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Opioids]]&lt;br /&gt;
[[Category:Synthetic drugs]]&lt;br /&gt;
[[Category:Benzimidazoles]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>